Localized and systemic bacterial infections in necrotizing pancreatitis submitted to surgical necrosectomy or percutaneous drainage of necrotic secretions

Table 2 Antibiotic resistance rates (%) of all the isolated bacteria among 46 patients with necrotizing pancreatitis

	E. coli	P. aeruginosa	K. pneumoniae	P. mirabilis	A. baumannii	E. faecium/faecalis	CNS	MRSA
Amoxi/Clavulanate	22	48	60	32	100	100	50	100
Amikacin	10	20	12	18	88	44	58	100
Ampi/Sulbactam	22	48	60	36	100	40	68	100
Cefotaxime	54	68	72	44	100	42	36	92
Ceftazidime	32	38	38	20	88	100	78	100
Ceftriaxone	40	60	44	42	100	100	56	92
Ciprofloxacin	24	82	62	26	92	42	22	78
Imipenem	2	12	8	0	24	-	-	-
Levofloxacin	24	82	52	16	100	40	20	56
Meropenem	0	6	2	0	16	-	-	-
Piperacillin/Tazobactam	22	48	26	16	58	90	40	100
Linezolid	-	-	-	-	-	2	0	2
Vancomycin	-	-	-	-	-	2	0	2
Rifampicin	80	100	68	88	2	2	0	68
Cotrimoxazole	32	100	40	38	100	100	0	50

MRSA: Methicillin-resistant Staphylococcus aureus; CNS: Coagulase negative Staphylococci

ISSN: 1471-2482